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Available online 28 November 2013Abstract Understanding the molecular basis of cardiomyocyte development is critical for understanding the pathogenesis of pre-
and post-natal cardiac disease. MicroRNAs (miRNAs) are post-transcriptional modulators of gene expression that play an important
role in many developmental processes. Here, we show that the miR-99a/let-7c cluster, mapping on human chromosome 21, is
involved in the control of cardiomyogenesis by altering epigenetic factors. By perturbing miRNA expression in mouse embryonic
stem cells, we find that let-7c promotes cardiomyogenesis by upregulating genes involved in mesoderm specification (T/Bra and
Nodal) and cardiac differentiation (Mesp1, Nkx2.5 and Tbx5). The action of let-7c is restricted to the early phase of mesoderm
formation at the expense of endoderm and its late activation redirects cells toward other mesodermal derivatives. The Polycomb
complex group protein Ezh2 is a direct target of let-7c, which promotes cardiac differentiation by modifying the H3K27me3 marks
from the promoters of crucial cardiac transcription factors (Nkx2.5, Mef2c, Tbx5). In contrast, miR-99a represses cardiac
differentiation via the nucleosome-remodeling factor Smarca5, attenuating the Nodal/Smad2 signaling. We demonstrated that the
identified targets are underexpressed in human Down syndrome fetal heart specimens. By perturbing the expression levels of these
miRNAs in embryonic stem cells, we were able to demonstrate that these miRNAs control lineage- and stage-specific transcription
factors, working in concert with chromatin modifiers to direct cardiomyogenesis.
© 2013 The Authors. Published by Elsevier B.V. All rights reserved.☆ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License,
which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
⁎ Corresponding author at: Department of Biophysics, Biochemistry and General Pathology, Seconda Università di Napoli, Via L. De Crecchio,
80138 Napoli, Italy. Fax: +39 081450169.
E-mail address: g.cobellis@unina2.it (G. Cobellis).
1 Epigenetics and Cell Fate, Université Paris Diderot, 75205 Paris, France.
1873-5061/$ - see front matter © 2013 The Authors. Published by Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.scr.2013.11.008
324 A. Coppola et al.Introduction host gene (Ozsolak et al., 2008). Experiments investigating theCardiomyogenesis proceeds through a cascade of signaling
events that operate in a spatial and temporal fashion to
specify cardiac cell fate during embryogenesis. The acqui-
sition and maintenance of cardiac-specific gene expression
are then mediated by epigenetic modifications. Different
histone modifications correlate with active, repressed, and
paused gene expression states and define cell identity (Burridge
et al., 2012). Nevertheless, despite important progress, our
current understanding of early steps of mammalian cardio-
myogenesis is far from complete, due to problems inherent to
the study of early cardiac specification in vivo.
This has favored the use of embryonic stem cells (ESCs) that
recapitulate cardiomyogenesis in vitro (Murry and Keller,
2008). Furthermore, ESCs represent a valuable model system
to use in disease modeling, drug screening and cell-based
therapy.
The discovery of long non-coding RNAs (lncRNA) and
microRNAs (miRNAs), in particular, has added a new layer of
complexity to our understanding of developmental process-
es. miRNAs are small (~21 nucleotide), non protein-coding
RNAs, which have emerged as key post-transcriptional
regulators of gene expression that act by targeting mRNAs
for translational repression or destabilization (Bartel, 2009;
Guo et al., 2010). In mammals, thousand of miRNAs with
distinct patterns of expression have been identified. These
control the activity of ~30% of all protein-coding genes.
Functional studies have indicated that miRNAs participate in
the regulation of almost every cellular process investigated
and different human pathologies, including cancer (Iorio and
Croce, 2012).
The essential role of miRNAs in the biology of stem cells was
clearly established by the finding that ESCs lacking proteins
required for miRNA biogenesis exhibit severe defects in
proliferation and differentiation (Kanellopoulou et al., 2005).
During heart development, deletion of cardiac Dicer results in
lethality at different developmental stages, depending on the
temporal expression pattern of the Cre transgene (Chen et al.,
2008). Postnatal deletion of Dicer causes disarray of cardiac
contractile proteins and sarcomeres, resulting in dilated car-
diomyopathy, heart failure, and death (da Costa Martins et al.,
2008). Recent studies have revealed central roles for some
miRNAs as regulators of gene expression during cardiovascular
development (Liu and Olson, 2010). The muscle-specific miR-1
was the first miRNA implicated in heart development (Zhao et
al., 2005). Targeted deletion of miR-1 highlighted numerous
functions of this miRNA in the heart, including regulation of
cardiac morphogenesis, electrical conduction, and cell cycle
control (Zhao et al., 2007).
Among the miRNAs potentially involved in cardiomyo-
genesis, miR-99a and let-7c are two intriguing candidates
as they are localized on human chromosome 21 (Hsa21).
Down syndrome (DS) is caused by the presence of a third
copy of Hsa21 and its phenotype includes congenital heart
defects in approximately 40% of cases (Antonarakis et al.,
2004).
MiR-99a and let-7c are organized in a cluster that resides
within intron 6 of the poorly characterized C21orf34 gene,
recently named LINC00478, localized to 21q21.1. They are only
659 basepairs (bp) apart and are supposed to be transcribed by
a specific intronic promoter that is different from that of thetissue distribution of expression of these miRNAs have demon-
strated that hsa-miR-99a and hsa-let-7c are upregulated
in fetal heart samples isolated from individuals with trisomy
21 (Ts21) (our unpublished data). Thus, it is tempting to
hypothesize that the deregulation of these miRNAs may play a
role in heart anomalies observed in DS.
In an effort to study the role of mmu-let-7c and mmu-
miR-99a in cardiomyogenesis using a gain-of-function system
in murine ESCs, we found that overexpressed let-7c increases
the expression of mesoderm- and cardiac-specific lineages by
targeting Ezh2, a member of the Polycomb group of proteins
(Delgado-Olguin et al., 2012). In differentiating cardiomyo-
cytes, let-7c increases the expression of Tbx5, Nkx2.5 and
Mef2C, reducing the H3K27 trimethylation marks in their
promoters. In contrast, miR-99a inhibits cardiomyogenesis by
attenuating the Nodal/Smad2 signaling, possibly via the
nucleosome-remodeling factor Smarca5 (Dirscherl and Krebs,
2004). We also demonstrated that the identified targets are
underexpressed in human DS fetal heart specimens. There-
fore, by perturbing the expression levels of these miRNAs in
ESCs, wewere able to show that thesemiRNAs control lineage-
and stage-specific transcription factors working in concert
with chromatin modifiers to direct the cardiomyogenesis.
Materials and methods
Cloning strategy
PCR primers with an AscI restriction site were designed to
amplify the genomic region containing mmu-miR-99a and
mmu-let-7c precursors. The sequences of the primers are
5′-GGCGCGCCTCTCAGGTAAAACGAAAAGGCACA-3′ and 5′-GG
CGCGCCCGTGCTAAGATAATATGCCTTTCC-3′. The amplified
fragment was cloned into the TOPO TA PCR II vector
(Invitrogen, Life Technologies Co.) and Sanger sequenced.
A let-7c construct was obtained by deletion of miR-99a
using the Quick Change XL Multi Site-Directed Mutagenesis
Kit (Stratagene, Life Technologies Co.) and the following
mutagenesis primers: 5′-GACGATGCCCATTGACATAAGTGAAG
TGGACCGCGCAAGC-3′ and 5′-GCTTGCGCGGTCCACTTCACT
TATGTCAATGGGCATCGTC-3′.
Similarly, a miR-99a construct was obtained using muta-
genesis primers 5′-GAAGCTGTGTGCATCCGGGTTAGAGTTACA
CCCTGGGAGT-3′ and 5′-ACTCCCAGGGTGTAACTCTAACCCGG
ATGCACACAGCTTC-3′.
The assembled constructs were cloned in the pPTHC
vector (Masui et al., 2005).
Cell culture
The cell line EBRTcH3 (EB3tet-off) was obtained from Dr. H.
Niwa and cultured as described (Masui et al., 2005). For
nucleofection experiment, 2 × 106 cells were transfected
with mouse ES cell Nucleofector kit (VPH-1001 Amaxa,
Lonza) in the presence of 6 μg of each miRNA precursor
plasmid in pPTHC vector and 3 μg of pCAGGS-Cre vector
(Araki et al., 1997), according to manufacturer's instruc-
tions. The day after the nucleofection, cells were cultured
with puromycin (1.5 μg/ml, Sigma-Aldrich Co.) for 7–8 days
before being transferred in two gelatin-coated 48-well
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presence of hygromycin (Sigma-Aldrich Co.) and the other
in the presence of puromycin to detect correctly exchanged
clones. The positive clones were identified by PCR using the
primers 5′-GCATCAAGTCGCTAAAGAAGAAAG-3′ and 5′-GAGT
GCTGGGGCGTCGGTTTCC-3′.
Induction of transgene expression
Three positive clones for each construct were tested for
inducibility to tetracycline, as reported (De Cegli et al.,
2010). Briefly, cells were washed twice with PBS, cultured
for 3 h in DMEM without tet, trypsinized, and re-plated onto
new dishes in medium deprived of tet. A time course was
performed in which cells were harvested and assayed at
18 h, 24 h, 36 h, and 48 h. Control cells were plated in the
presence of tet.
Real-time PCR
For miRNA expression, total RNA was transcribed using
the TaqMan MicroRNA Reverse Transcription Kit (Applied
Biosystems, Life Technologies Co.). The mature miR se-
quence for miR-99a is ACCCGUAGAUCCGAUCUUGU and
for let-7c is UGAGGUAGUAGGUUGUAUGGUU. For an exact
comparison of miRNA quantity, four reference microRNAs
(mmu-miR-26a UUCAAGUAAUCCAGGAUAGGCU,mmu-miR-
29a UAGCACCAUCUGAAAUCGGUU,mmu-miR-27a UUCACAG
UGGCUAAGUUCCGC, and snRNU6) were used and analyzed
by the geNorm algorithm (Vandesompele et al., 2002).
For cDNA expression, 1 μg of total RNA was reverse-
transcribed by QuantiTect Reverse Transcription Kit (Qiagen
Co.). Real-time PCR was performed using the Light Cycler
SYBR Green PCR Kit (Bio-Rad Co.) and Bio-Rad CFX96
real-time PCR system for signal detection.
Embryonic stem cell differentiation
Differentiation of ESCs through embryoid body (EB) formation
was performed using the standard hanging drop method in
DMEM supplementedwith 15% FBS, 0.1 mMβ-mercaptoethanol,
1 mM sodium pyruvate, 2 mM glutamine, and 100 U/ml
penicillin/streptomycin (Gibco-Life Technologies Co.).
Flow cytometry
Embryoid bodies were dissociated with trypsin into a
single-cell suspension (2 × 106 cells), washed with 10% FBS/
DMEM, and permeabilized with 0.05% saponin/PBS buffer for
20 min on ice. Cells were stained with the myosin-specific
antibody MF-20 (Developmental Studies Hybridoma Bank,
Iowa, IA, USA) that was diluted 1:100 in 10%FBS/DMEM for
1 h. Cells were then incubated with an anti-mouse antibody
conjugated to FITC (dilution 1:100 in 10% FBS/DMEM) for
30 min in the dark. After two additional washes in 10% FBS/
DMEM, cells were resuspended in 500 μl 10% FBS/DMEM and
analyzed on a FACS instrument (Becton-Dickinson Co.). The
number of labeled cells was analyzed by FlowJo software,
using cells incubated with secondary antibodies as a
reference.Western blotting
ESCs were lysed in 20 mM Tris–HCl (pH7.4), 100 mM NaCl,
10 mM MgCl2, 1% NP-40, 10% glycerol, 100 μM Na3VO4 and
a protease inhibitor mixture (Roche Applied Science).
Cell extracts were separated by SDS-polyacrylamide gel
electrophoresis and transferred to nitrocellulose by semi-
dry blotting.
Phospho-Smad2 (Ser465/467), total Smad2 (Cell Signaling
Technology), EZH2 (Abcam), Smarca5 (Santa Cruz Biotech-
nology, Inc.), and tubulin antibodies were used. Densito-
metric analysis of the bands was performed using ImageJ
software.
Microarray hybridization
Total RNA was extracted from induced and uninduced cells
using Trizol reagent (Gibco, Life Technologies). Three micro-
grams of total RNA was reverse transcribed to single-stranded
cDNA with the One-Cycle cDNA synthesis kit by Affymetrix.
Biotinylated aRNA was generated using the GeneChip IVT
labeling kit (Affymetrix, Inc.). 20 μg of biotinylated aRNA was
fragmented, and 10 μg was hybridized to the Affymetrix
GeneChip Mouse Genome 430 2.0 array for 16 h at 45 °C using
an Affymetrix GeneChip Fluidics Station 450 Analysis to convert
probe level data to gene level expression data was done using
Robust Multiarray Average (RMA) software contained in the
Affymetrix package from the Bioconductor project (http://
www.bioconductor.org) (Gentleman et al., 2004).
The array results were deposited in the Array Express
database with the following accession number: E-MEXP-3748.
Cell transfection
miScript miRNA mimics miR-99a (MSY0000064), let-7c
(MSY0000062) and miScript miRNA inhibitors anti-miR-99a
(MIN0000131), anti-let-7c (MIN0000131) were purchased
from Qiagen Co. and transfected into undifferentiated ESCs
using Lipofectamine 2000 (Invitrogen, Life Technologies
Co.) according to the manufacturer's instructions. For
experiments with undifferentiated ESCs, cells were recov-
ered after 48 h for analysis.
The 3′-UTR fragments were cloned in the pMIR-REPORT
Luciferase vector (Ambion, Life Technologies). 3 × 104 ESCs
were transfected with 400 ng of reporter construct and 200 ng
of control renilla vector (phRLTK, Promega) using Lipofecta-
mine 2000 (Invitrogen, Life Technologies Co.). Reporter activity
was measured using the Dual Luciferase Reporter Assay System
(Promega Co.) on a LB9507 Luminometer (Berthold Technolo-
gies, DE) and expressed as relative luciferase activity.
Mutations in the 3′UTR of Ezh2 and Smarca5 were done using
the Quick Change XL Multi Site-Directed Mutagenesis Kit
(Stratagene, Life Technologies Co.).
Chip-qPCR
Mouse EBs were chemically cross-linked with 11% formalde-
hyde solution for 15 min at room temperature. After a
glycine/PBS wash, cells were lysed with 0.1% SDS, 0.5%
Triton X-100, 20 mM Tris–HCl (pH 8), 150 mM NaCl, and
protease inhibitor, and sonicated on ice using three 30 s
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from 200 bp to 500 bp in size. The resulting whole-cell
extract was incubated with anti-H3K27me3 and anti-H3K4me3
(Abcam) antibodies overnight at 4 °C. The immunocomplexes
were collected on protein-G Sepharose, washed twice with
lysis buffer, twice with washing buffer (0.1% SDS, 0.5% TritonX-100, 2 mM EDTA (pH 8), 20 mM Tris–HCl (pH 8), 150 mM
NaCl, and protease inhibitor), once with LiCl buffer (0.25 mM
LiCl, 1% NP-40, 1% deoxycholate, 1 mM EDTA (pH 8), 10 mM
Tris–HCl (pH 8), and protease inhibitors). Bound immuno-
complexes were eluted with elution buffer (1% SDS, 0.1 M
NaHCO3 pH 8), mixed with 10 μl of 5 M NaCl per sample
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was purified by multiple phenol:chloroform:isoamyl alco-
hol extractions. Purified DNA was used as template for
qPCR to amplify the proximal promoter regions of Oct3/4,
Nkx2.5, Mef2c, and Tbx5.
Human fetal heart RNA
Human fetal heart RNAs, age- (18–20 weeks of gestation)
and sex-matched controls (n = 3) and DS specimens (n = 3),
were collected at Department of Molecular Medicine and
Biotechnology, University of Napoli ‘Federico II’.
Statistical analysis
Data are presented as the mean ± SEM of replicates (n = 3).
Statistical significance was calculated using Student's two-
tailed t-test for unpaired comparison or by the ANOVA
analysis with Bonferroni post-hoc correction for multiple
comparisons using SPSS 17 software (IBM). p-Values b 0.05
were considered significant.
Results
let-7c and miR-99a are regulated during cardiac
differentiation
To gain insight into the biological activity of these miRNAs,
miR-99a and let-7c expression in mouse ESCs (mESCs) was
assessed by quantitative RT-PCR (RT-qPCR). RNA was col-
lected from undifferentiated cells and from differentiated
cardiomyocytes taken from embryoid bodies (EBs) up to day
7, which correspond to the appearance of functional
cardiomyocytes (Murry and Keller, 2008).
RT-qPCR analysis showed that let-7c was expressed in
undifferentiated ESCs and differentiating EBs up to day 5,
when it was significantly downregulated (-3.5× fold, p b 0.05;
Fig. 1A). From day 6 onward, let-7c was progressively induced
(10×, p b 0.05; Fig. 1A). In contrast, miR-99a was not
detectable in undifferentiated ESCs as well as in differentiat-
ing EBs up to day 6, when it became significantly upregulated
(25×, p b 0.05; Fig. 1A). These results indicated that these
miRNAs showed different expression profile during cardiac
differentiation.
Next, the endogenous expression of these two miRNAs
was perturbed in an attempt to reveal their functions. ESCs
were generated that overexpressed the pre-miRNAs through
a Cre-mediated cassette exchange into the Rosa26 dockingFigure 1 let-7c and miR-99a are expressed during cardiac dif
undifferentiated ESC (E14Tg2a.4 T0) and in embryoid bodies throughou
and reported as fold induction. B) Schematic representation of experim
were inserted into the modified exchange vector and linearly nucleofect
cells (EB3-tet off). Correctly exchanged clones were identified by PCR an
and mir-99a (right panel) expression measured by RT-qPCR in three inde
B7) and miR-99aΔlet-7c (cl. B3, B5, and B6), respectively. Data were no
reported as fold induction relative to uninduced cells (+tet, T0, black
miR-99a expression in three independent let-7c/miR-99a overexpressing
fold induction relative to uninduced cells (+tet, T0, black bars).site of recipient cells using the ROSA-TET system (De Cegli
et al., 2010) (Fig. 1B). Since let-7c and miR-99a are adjacent
on murine chromosome 16, we produced stable ESCs overex-
pressing: a) both pre-miRNAs (let-7c/miR-99a clone), b) let-7c
pre-miRNA with a deletion in miR-99a (let-7cΔmiR-99a
clone) and c) miR-99a pre-miRNA with a deletion in let-7c
(miR-99aΔlet-7c clone). Three positive clones for each
pre-miRNAs were identified and time course experiments
were performed to verify the miRNAs induction by RT-qPCR
in the absence of tetracycline (tet) at 18, 24, 36, and 48 h.
In all the clones analyzed, let-7c (A5, A8, B7), miR-99a (B3,
B5, B6) as well as let7c/mir-99a (A2, A7, B2) were nicely
induced at 18 after tet removal, thus indicating that the
ROSA-TET inducible system allowed efficient and rapid
overexpression of both single and paired miRNAs (Figs. 1C
and D).let-7c overexpression increases mesoderm
formation toward cardiac differentiation
To investigate the contribution of these miRNAs in
cardiomyogenesis, we decided to exploit the overexpres-
sion of let-7c and miR-99a during the early stages of cardiac
differentiation by performing gene expression studies.
Interestingly, let-7c overexpression, after 18 h of induction
(Supplementary Fig. 1A), resulted in increased expression
of mesodermal genes (Nodal, T/Brachyury) and early
cardiac transcription factors (Mesp1, Gata4 and Mef2C)
(Fig. 2A), whereas miR-99a overexpressing clones showed a
down-regulation of mesodermal cardiac genes (Mesp1,
Nkx2.5 and Mef2c) (Fig. 2A). Expression of the selected
genes remained largely unchanged in let-7c/miR-99a
overexpressing clones (Supplementary Fig. 1B).
To further investigate the effects of miRNA overexpression
on cardiac differentiation, ESCs were allowed to aggregate in
EBs up to day 5 (T5). We first verified that let-7c and miR-99a
overexpression persisted in 5 day-old EBs, indicating that the
ROSA-TET system allowed sustained expression of miRNAs
throughout differentiation (Supplementary Fig. 1C). In line
with previous data, the overexpression of let-7c increased
expression of cardiac transcription factors Tbx5,Mesp1, Nkx2.5
and Mef2C (Fig. 2B). In contrast, miR-99a overexpressing EBs
showed a significant down-regulation of Tbx5 and Mef2C,
compared to a control (Fig. 2B). No significant difference was
observed in let-7c/miR-99a overexpressing EBs (Supplementary
Fig. 1D).
To assess the relevance of our findings, we knocked down
let-7c and miR-99a in ESCs using chemically synthesized
inhibitors (anti-let-7c and anti-miR-99a) at two differentferentiation. A) Endogenous let-7c and miR-99a expression in
t cardiac differentiation. Expression was normalized to U6 snRNA
ental system. Genomic fragments containing each miRNA precursor
ed with Cre recombinase expression vector into RMCE-modified ESC
alysis on genomic DNA. C) Time course analysis of let7-c (left panel)
pendent overexpressing clones: i.e. let-7cΔmiR-99a (cl. A5, A8, and
rmalized to unrelated miRNAs (miR-26a, miR-27a and miR-29a) and
bars) at indicated time points (0, 18, 24, 36, and 48 h). D) let-7c/
clones (cl. A2, A7, and B2) at 0, 18, and 24 h. Data were reported as
Figure 2 let-7c increases the transcription of genes relevant to cardiomyogenesis. A) Expression of mesodermal genes (Nodal and
T/Bra) and precardiac transcription factors (Mesp1, Nkx2.5, Gata4 and Mef2c) in undifferentiated cells overexpressing let-7c or
miR-99a after 18 h of miR induction. Gene expression data were reported as 2-ΔΔCt method, normalized to housekeeping genes
(β-actin and GAPDH mRNAs). B) Expression of cardiac transcription factors (Tbx5, Mesp1, Nkx2.5, Mef2c, Gata4 and Isl1) in
differentiating EBs after 5 days of miR induction. Gene expression data are reported as 2-ΔΔCt method, normalized to housekeeping
genes (β-actin and GAPDH mRNAs). Data are the mean ± SEM of three experiments in three independent clones.* p b 0.05. C) Effects
of anti-let-7c and anti-miR-99a on genes relevant to cardiac differentiation. Wild-type ESC cells were transfected with the synthetic
inhibitor anti-miR (80 nM) and analyzed for the expression of Nodal, T/Bra, Mesp1, Nkx2.5, Gata4 and Mef2c by RT-qPCR. Normalized
gene expression data were reported as 2-ΔΔCt method between transfected vs untransfected cells. Data are the mean ± SEM.
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in wild type ESCs and led to a significant down-regulation of
endogenous miRNAs in a dose-dependent manner (Supplemen-
tary Fig. 2A). Interestingly, anti-let-7c decreased expression of
mesodermal cardiac markers (Fig. 2C), whereas anti-miR-99a
did not alter their expression (Fig. 2C), indicating that
endogenous let-7c is indeed involved in the regulation of
mesodermal gene expression in mESCs.
To verify whether a full program of cardiomyogenesis
occurred in let-7c overexpressing ESCs, a quantitative analysis
of terminally differentiated cardiomyocytes was performed byFigure 3 let-7c increases the number of cardiomyocytes. ESCs
were allowed to differentiate in cardiomyocytes via EBs formation
in the presence (black squares) and in the absence of tet (gray
triangles). Myosin-positive cells measured by FACS at days 5, 8, 9,
and 12 of differentiation with themyosin-specific antibody MF-20:
A) miR-99aΔlet-7c cl. B3 and B6; B) let-7cΔmiR-99a cl. A5 and A8;
and C) let-7c/miR-99a cl. A2 and B2. Data represent mean ± SEM
of three experiments in two biologically independent clones.
* p b 0.05.FACS analysis, in which cells had been immunostainedwith the
anti-sarcomeric myosin antibody MF-20. Overexpression of
let-7c resulted in a significant increase in MF-20-positive cells
throughout the differentiation process (Fig. 3A). In contrast, a
significant decrease in MF-20 positive cells was observed in
miR-99aΔlet-7c EBs from day 9 onward (Fig. 3B). A comparable
number of cardiomyocytes was observed in let-7c/miR-99a
overexpressing EBs, compared to uninduced EBs (Fig. 3C).
Collectively, these results suggested that let-7c and miR-99a
are both involved in cardiomyogenesis. let-7c regulates
mesoderm- and cardiac-specific transcription factors, where-
as miR-99a is involved in cardiomyogenesis, but does not
regulate the expression of these genes.Temporally regulated let-7c overexpression enhances
cardiomyogenesis
Knowing that mesoderm commitment is temporally regulated
(Colas et al., 2012), we sought to identify the precise timing
through which let-7c promotes cardiomyogenesis by overex-
pressing the miRNA before and after mesoderm specification.
let-7cΔmiR-99a ESCs were induced to differentiate in the
presence or absence of tet from day 2 to day 4 (T2-T4), or from
day 5 onward (T5 long, Fig. 4A).
As expected, let-7c was induced twofold and then returned
to basal levels after adding tet back into the culture medium
in the T2–T4 experiment (Fig. 4A), while it was induced from
day 6 onward in the T5 long experiment (Fig. 4A). Interest-
ingly, the number of MF-20 positive cells increased (3.5× at
T12, p b 0.05) throughout ESC cardiac differentiation in the
T2–T4 experiment (Fig. 4B). In contrast, in the T5 long
experiment, the number of MF-20 positive cells was compa-
rable in induced and control cells up to T9, but then it
significantly decreased in the overexpressing cells (−2×,
p b 0.05; Fig. 4B).
In line with these findings, RT-qPCR analysis performed
on EBs at day 5 confirmed that let-7c was able to up-regulate
expression of cardiogenic transcription factors (Tbx5, Mesp1
and Mef2c) only when overexpressed in the T2–T4 interval
(Fig. 4C), whereas a consistent downregulation of these
genes was observed when let-7c was induced from day 5
onward (Fig. 4D).
Interestingly, while expression of the mesendodermal
markers Gata4 and Sox17 was not significantly altered when
let-7c was induced from day 2 to day 4 (Fig. 4C), both genes
were strongly upregulated upon overexpression of let-7c from
day 5 onward (Figs. 4C and D). A possible explanation of the
observed phenotype is that the T2-T4 let-7c overexpression
promotes mesoderm differentiation, which eventually results
in increased cardiomyogenesis. In line with this idea, a recent
study showed that the days 3–5 of mESC differentiation span
the developmental window in which the mesendoderm
progenitors coexist and that later on give rise to mesoderm
and endoderm (Colas et al., 2012). The late activation of
Gata4 and Sox17 marks the endoderm expansion, as reported
in Frankenberg et al. (2011).
To verify that up-regulation of cardiac transcription factors
corresponded to an increase in mesoderm differentiation, the
expression of genetic markers of cardiac progenitors (Flk1,
PdgfRα, Tdgf1/Cripto, desmin), was measured (D'Aniello et
al., 2009; McLendon and Robbins, 2011). A significant
330 A. Coppola et al.upregulation of almost these genes was observed, when let-7c
was induced in T2–T4 interval (Fig. 4F).
Moreover, since let-7c has also been implicated in
endothelial cell differentiation (Colas et al., 2012), we
examined the expression of the endothelial specific markersVE-cadherin (Cdh5), Pecam1 and Pdgfβ. Interestingly, these
genes were upregulated in the clones overexpressing let-7c
from day 5 onward (Fig. 4F), suggesting that cardiac but not
the endothelial differentiation was impaired upon overex-
pression of let-7c form day 5 onward.
331Cardiomyogenesis is controlled by the miR-99a/let-7c cluster and epigenetic modificationsEzh2 is a functional target of let-7c
To identify potential mRNA targets of let-7c and miR-99a
that could explain our findings, we used the Co-expression
Meta-analysis of miRNA Targets (CoMeTa) software (Gennarino
et al., 2012). Gene Ontology analysis was performed on the
computationally predicted targets of let-7c and miR-99a.
Among the most prominently affected terms of putative
let-7c targets, we found the terms developmental process
(p-value 4E−6) and heart development (p-value 8E−2). Potential
targets were selected based on the presence of let-7c
recognition sites in their 3′UTR. Among thesewas the Polycomb
complex group (PcG) protein Ezh2, a methyltransferase, which
acts as silencer of differentiation pathways in ESCs, already
known to regulate cardiac gene expression and differentiation
(Barrero et al., 2010; Caretti et al., 2004; Sauvageau and
Sauvageau, 2010). Ezh2 mRNA inversely correlated with let-7c
expression during cardiac differentiation (Fig. 5A). Next, we
tested whether let-7c could directly target the computation-
ally predicted recognition sites in the 3′UTR of the Ezh2mRNAs.
The 3′UTR was placed downstream from a luciferase ORF (luc)
under the control of the cytomegalovirus (CMV) promoter. Inwt
ESC transfection, mimic let-7c repressed luciferase activity of
the CMV-Luc-Ezh2 3′UTR construct (75% at 40 nM, 90% at
80 nM, p b 0.05; Fig. 5B). No repression in luciferase activity
was observed when cells were transfected with the construct
containing a mutation in the let-7c recognition site, confirming
that the binding is specific (Fig. 5B). A let-7c overexpressing
clone (cl. A5) was also used to perform the luciferase assay.
Transfection with the CMV-Luc-Ezh2 3′UTR led to significant
suppression of luciferase activity when let-7c was induced by
tet removal, compared to a control (90%, p b 0.05; Supple-
mentary Fig. 3A). No changes in luciferase activity were ob-
served when the CMV-Luc-Ezh2 3′UTR was transfected into ESC
clones, in which let-7c was mutated (Supplementary Fig. 3A).
We subsequently verified that let-7c affected the levels
of the endogenous Ezh2 transcript and protein, using the
mimic and anti-miR approach. After verifying the efficacy of
such tools in ESCs (Supplementary Figs. 2A and 3B), tests
showed that let-7c led to consistent repression of endoge-
nous Ezh2 mRNAs (Fig. 5C) and protein (Fig. 5D), as well as
up-regulation of Ezh2 protein in the presence of anti-let-7c
(Fig. 5E). Taken together, these data indicate that Ezh2 is a
direct target of let-7c.
There are 10 members of the let-7 family in the mouse
genome (Roush and Slack, 2008). It was shown recently that
the entire family controls mesoderm segregation in mouse
ESCs (Colas et al., 2012). On that basis, another member ofFigure 4 let-7c action is restricted to a narrow time window. A) le
obtained by tet removal from day 2 to day 4 of differentiation (T2–T
normalized to snRNAU6 and reported as fold induction. Data represent
clones. B) MF-20-positive cells measured by FACS in let-7cΔmiR-99a over
Cells were allowed to differentiate in cardiomyocytes in the presence o
mean ± SEM of three independent experiments in two independent clon
(Tbx5, Mesp1, Nkx2.5, Mef2c) endoderm markers (Gata4 and Sox17)
Desmin, Pdgfβ) by RT-qPCR in differentiating EBs at day 5 in T2–T4 expe
Mesp1, Nkx2.5, Mef2c) endoderm markers (Gata4 and Sox17) and line
Pdgfβ) by RT-qPCR in differentiating EBs at day 6 in T5 long experiment.
and are the mean ± SEM of three experiments in two independent clonethe family, let-7a, which is known to target Lin28, was
tested for its ability to target Ezh2. Mimic let-7a and let-7c
(40 nM and 80 nM) were transfected into wild type ESCs
(Supplementary Figs. 4A and 3B). Both let-7a and let-7c
caused similar repression of endogenous Ezh2 and Lin28
mRNAs (Supplementary Fig. 4B), indicating that the function
of let-7 family members could be redundant.
Ezh2 and histone modifications are required to
promote cardiac differentiation
Chromatin occupancy studies have revealed that the
methyltransferase activity of Ezh2 catalyzes histone H3
methylation at lysine 27 at promoters of developmental
regulators. This silences these promoters in ESCs (Bernstein
et al., 2006). These targets display ‘bivalent’ chromatin
marks, defined by the presence of active H3K4me3 and
repressive H3K27me3 marks. We investigated whether let-7c
could modify the H3K4/H3K27me3 marks at promoters of
cardiac transcription factors. To directly address this issue,
EBs were allowed to differentiate up to day 5, when
chromatin immunoprecipitation (ChIP) was performed with
antibodies specific to H3K4me3 and H3K27me3 histone modi-
fications. ChIP combined with qPCR revealed that Nkx2.5,
Mef2c, and Tbx5 promoters showed an overall reduction in
H3K27me3 marks in let-7c overexpressing cells with a concom-
itant increase of H3K4me3 marks (Fig. 5F, left panel).
To exclude that the observed differences of H3K4/H3K27
trimethylation patterns in 5 day-old EBswasmerely an artifact
arising from in vitro differentiation, we examined the same
regions in EBs overexpressing GFP. In this analysis, cardiac-
specific regions showed no dramatic difference in H3K27me3
compared to H3K4me3 (Fig. 5F, right panel). Therefore, let-7c
is able to positively regulate cardiomyogenesis by modifying
histone marks of cardiac transcription factors in EBs at day 5,
leading to their transcriptional derepression.
miR-99a targets Smarca5 leading to defective
Nodal signaling
Gene Ontology analysis on the computationally predicted
targets of miR-99a identified chromatin regulator as the
most affected term (p-value 3.2E−3). Among these, a
potential target for the miR-99a/miR-100 family is Smarca5
(also known as Snf2h) (Tarantino et al., 2010). Smarca5
encodes the catalytic subunit of ATP-dependent chromatin
remodeling complexes, which is conserved in both structure
and function across species (Corona and Tamkun, 2004;t-7c overexpression in let-7cΔmiR-99a clones (cl. A5 and A8) was
4) and from day 5 onward (T5 long). miRNA expression level was
mean ± SEM of three experiments in two biologically independent
expressing cells in both experimental settings (T2–T4 and T5 long).
f tet (black squares) or without tet (gray triangles). Data represent
es (*, p b 0.05). C) and E) Expression of cardiac transcription factors
and lineage-specific genes (Flk1, PdgfRα, Cdh5, Cripto, Pecam1,
riment. D) and F) Expression of cardiac transcription factors (Tbx5,
age-specific genes (Flk1, PdgfRα, Cdh5, Cripto, Pecam1, Desmin,
Normalized gene expression data were reported as 2-ΔΔCt method
s.* p b 0.05.
Figure 5 Ezh2 is the direct target of let-7c. A) Seed sequence present in the 3′UTRof Ezh2 gene boundbymature let-7c. Expression analysis
of endogenous let-7c and Ezh2 throughout differentiation process in wt ESC by RT-qPCR. Normalized gene expression data were reported as
2-ΔCt method. B) Luciferase assay: ESCs transfected with CMV-luc 3′UTR Ezh2 in the presence of miRNA mimic let-7c at two concentrations
(40 nM and 80 nM). C) miRmimic and scramblemiRNA (black bar) were analyzed by RT-qPCR and Ezh2 expression reported. D and E) Western
blotting analysis of Ezh2 protein in ESCs transfected with mimic and anti-miR against let-7c. Tubulin antibody was used as loading control.
F) ChIP analysis: chromatin immunoprecipitation (ChIP)was performed on EBs at day 5 on let-7c overexpressing cloneswith antibodies specific
to H3K4me3 and H3K27me3 histone modifications (left panel) and compared to GFP-overexpressing cells (right panel). Data analyzed by
RT-qPCR are themean ± SEM of three experiments and reported as the ratio between induced cells vs uninduced cells, relative to their input.
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Figure 6 miR-99a targets Smarca5 and causes defective Nodal signaling. A) Seed match of the sequence present in the 3′UTR of Smarca5
gene and positions 2–7 of the mature miR-99a. Expression analysis of endogenous miR-99a and Smarca5 was measured throughout the
differentiation process by RT-qPCR. Normalized gene expression data were reported as ΔCt method. B) Luciferase assay: ESCs transfected
with CMV-luc 3′UTR-Smarca5 in presence of mimic miR-99a at two different concentrations (40 nM and 80 nM). C) Effects of anti-miR-99a.
Transfected ESC with anti-miR-99a (50 nM gray bar and 80 nM white bar) and scramble miRNA (black bar) were analyzed by RT-qPCR.
miR-99a expression was reported as fold change compared to control. D) Effect of anti-miR-99a on Smarca5 protein visualized by western
blotting analysis. Tubulin antibody was used as loading control. E) Cell lysates of miR-99a overexpressing clones were analyzed for pSmad2
by immunoblot analysis throughout the differentiation process at T0, T2, T5, T7 and T9 in miR-99a overexpressing cells and compared to
uninduced ones. Total SMAD2 antibody was used to normalize F) Protein levels were reported as arbitrary units after densitometric analysis
performed by ImageJ. G) ChIP analysis: chromatin immunoprecipitation (ChIP) was performed on EBs at day 5 on miR-99a overexpressing
clones with antibodies specific to H3K4me3 and H3K27me3 histone modifications. Data analyzed by RT-qPCR are the mean ± SEM of three
experiments and reported as the ratio between induced cells vs uninduced cells, relative to their input.
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334 A. Coppola et al.Dirscherl and Krebs, 2004). Smarca5 knockout embryos die
during the pre-implantation stage, suggesting a role for
Smarca5 in early mouse development (Stopka and Skoultchi,
2003). Based on the above observations, Smarca5 was tested
as a potential target for miR-99a.
Smarca5 expression was analyzed by RT-qPCR throughout
differentiation of the cells. As shown in Fig. 6A, Smarca5 was
expressed at T0 and was suddenly downregulated following
miR-99a induction, as expected in the case of a miR-99a
targeting of Smarca5.
A luciferase reporter assay was performed with the
CMV-Luc-Smarca5 3′UTR containing the miR-99a target site.
In wt ESCs, miR-99a transfection repressed luciferase activity
of the CMV-Luc-Smarca5 3′UTR construct (60% at 80 nM,
p b 0.05; Fig. 6B). No repression in luciferase activity was
observed when the miR-99a recognition site was mutated,
confirming that the binding is specific (Fig. 6B). Furthermore,
inhibition of luciferase constructs in a miR-99 overexpressing
clone (B6) caused a significant suppression of the CMV-Luc-
Smarca5 3′UTR construct when miR-99a was overexpressed
(50%, Supplementary Fig. 5).
Next, the effect of miR-99a on the levels of endogenous
Smarca5 protein was assessed. Wild type ESCs were transfected
with synthetic miR-99a inhibitor (anti-miR-99a) that efficiently
down-regulated endogenous miR-99a (55%, p b 0.05) (Fig. 6C).
This resulted in increased levels of Smarca5 protein (Fig. 6D),
indicating that Smarca5 is a target of miR-99a.
To gain insight into how miR-99a controls cardiac differen-
tiation, gene expression profiling was performed using
Affymetrix MOE 4.0 arrays. Three biological replicates of the
miR-99aΔlet-7c overexpressing clones were combined for
subsequent analysis. Control and miR-99a overexpressing ESCs
(+/−tet) were compared, applying the following statistical
threshold: fold changes≥2 and p-values ≤ 0.05. Although only
a limited number of genes (119 genes) passed this threshold,
Gene Ontology was used successfully to identify the most
relevant biological terms, which included the TGFβ pathway. A
significant downregulation of TGFβ family members was found,
such as Lefty1 (fold change -2.79; p-value 7.42E−05) and Lefty2
(fold change −2.13, p-value 8.3E−03), the Nodal/Smad down-
stream target FoxH1 (fold change −2.15; p-value 3.14E−06) and
the Sox17 gene (fold change −2.03; p-value 2.5E−02) (Fei et al.,
2010).
To look for a functional interaction between miR-99a and
TGFβ signaling, we used immunoblot analysis to measure the
phosphorylation status of the Smad2 protein, the downstream
effector of this pathway, which is required for differentiation
toward the mesendoderm lineage (Fei et al., 2010; Kitamura
et al., 2007). Smad2 phosphorylation showed the expected
bimodal profile in uninduced cells (+tet), being down-regulated
at day 5, which nicely fits with the appearance of cardiac
precursors, whereas in miR-99a overexpressing clones pSmad2
levels persisted throughout differentiation (Fig. 6F). Loss of
bimodal activation of pSmad2 in miR-99a overexpressing clones
is consistent with a reduction of cardiac mesoderm commit-
ment, indicating a functional relationship between miR99a and
Smad2 signaling.
We also investigated whether miR-99a could modify the
H3K4/H3K27me3 marks at promoters of cardiac transcrip-
tion factors. To directly address this issue, EBs were allowed
to differentiate up to day 5, when chromatin immunopre-
cipitation (ChIP) was performed with antibodies specificto H3K4me3 and H3K27me3 histone modifications. ChIP
combined with qPCR revealed an increased prevalence of
H3K27me3 repressive marks at the cardiac promoters in
miR-99a overexpressing cells (Fig. 6G).
Ezh2 and Smarca5 are under expressed in human DS
fetal hearts
To extend our findings and to determine whether the
identified targets were aberrantly expressed in DS samples,
total RNA was isolated from human euploid (n = 3) and DS
fetal heart tissues (n = 3) and expression of Ezh2 and
Smarca5 determined by RT-qPCR. As shown in Fig. 7a, the
expression of Ezh2 and Smarca5 was significantly downreg-
ulated in DS vs euploid heart tissues and this downregulation
is paralleled by an increase expression of the two miRNAs,
let-7c and miR-99a, indicating that the action of these
miRNAs can be relevant for cardiac development.
Discussion
Here, we report the role of mmu-let-7c and mmu-miR-99a in
cardiomyogenesis using an overexpression strategy in murine
embryonic stem cells. Gene expression is fundamental for the
functioning of cellular processes and is tightly regulated.
Inducible promoters allow gene expression to be perturbed by
changing the expression level of a genetic element (protein-
coding gene, miRNA, lncRNA) from its physiological level. This
is a common tool for deciphering the functioning of biological
processes: the expression level is altered and one observes how
the perturbed cell behaves differently from an unperturbed
cell. Using our system, the physiological expression levels of
let-7c and miR-99a were manipulated. Our results show that
let-7c controls lineage- and stage-specific transcription fac-
tors, and works in concert with Ezh2 to direct cardiogenesis.
We also demonstrated that precise perturbations at different
points in time were particularly informative: let-7c induces
cardiogenesis only when overexpressed during the time that
mesoderm is emerging. Conversely, miR-99a appears to repress
cardiogenesis by altering the Smad2 signaling, when over-
expressed at early stage of differentiation. However, although
our system consistently overexpresses the miRNA, we cannot
determine the precise timing of the miR-99a effects, since the
endogenous form of this miRNA is so highly expressed from day
6 onward during cardiac differentiation, it was not possible to
overcome the endogenous expression level.
It is well established that chromatin modifier enzymes
control pluripotency and differentiation in stem cells by
modulating transcription factor activity. In epidermal cells,
epigenetic regulation is the basis of its correct differentia-
tion program and many chromatin-associated factors are
involved, such as EZH2, UHRF1 (both known to regulate
epidermal self-renewal), ING5 (a MORF complex compo-
nent), BPTF and SMARCA5 (NURF complex components)
(Mulder et al., 2012). Our experiments revealed that Ezh2
and Smarca5 are involved in cardiac differentiation of ESCs
and that the miR99a/let-7c cluster controls their action. In
particular, let-7c mediates repression of Ezh2, which is
critical for silencing promoters of developmental regulators
by H3 methylation at lysine 27. On the other hand, miR-99a
targets Smarca5, which might correlate with decreased
335Cardiomyogenesis is controlled by the miR-99a/let-7c cluster and epigenetic modificationsNodal signaling leading to defective cardiomyogenesis.
Hypothetic model explaining how miR99a/let-7c cluster
may contribute to cardiomyogenesis is shown in Fig. 7b.
To the best of our knowledge, our study has revealed for
the first time that a miRNA cluster exerts opposite effects
on the same biological process. Due to their counteractiveFigure 7 A) Expression analysis of Ezh2 and Smarca5 in human DS fe
age- and sex-matched. Expression analysis of the two miRNA in human
method. B) Model depicting the miR99a/let-7c cluster action involvedfunction, it is tempting to hypothesize that these two
miRNAs could regulate each other or could be regulated by
different promoters and/or regulatory elements activated at
different times throughout the differentiation program.
Therefore, further studies are needed to gain insight into
the regulation of expression of these two miRNAs. Thetal heart specimens (n = 3) compared to euploid samples (n = 3),
samples. Normalized gene expression data were reported as 2-ΔCt
in cardiac differentiation.
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extended to other cellular systems. Previous studies have
shown that let-7c controls the androgen signaling in prostate
cancer by down-regulating androgen receptor expression
(Nadiminty et al., 2012a, 2012b). Loss of the let-7 miRNA
family correlates with EZH2 upregulation in prostate cancer
cells, which contributes to cancer aggressiveness (Kong et
al., 2012). Also miR-99a is expressed in prostate cancer
cells, where it suppresses the expression of prostate-specific
antigen and controls prostate cancer cell proliferation (Sun
et al., 2011). However, no data are currently available on
potential interactions between these miRNAs.
Gene regulation in pluripotent stem cells is dependent on
the activity of several multiprotein complexes, including
Polycomb Repressive Complex (PRC), that influence tran-
scription by modifying chromatin. In mammals, two PRC2
catalytic subunits are known: the E(z)-related genes, which
methylate lysine 27 of histone H3, leading to transcriptional
repression of target genes (Laible et al., 1997). Ezh1 is
expressed prevalently in the adult, whereas Ezh2 is expressed
during murine embryonic development and is involved in
safeguarding embryonic stem cell identity and proper devel-
opment. Indeed, Ezh2-null mouse embryos die during the
transition from pre- to post-implantation development
(O'Carroll et al., 2001). Furthermore, in myotome compart-
mentalization, a crucial role of Ezh2 occurs at an early stage of
development, when its downregulation coincides with activa-
tion of skeletal muscle differentiation at later stages (Juan et
al., 2011). In the heart, Ezh2 is important for stabilizing
cardiac gene expression, by depositing epigenetic repression
marks during an early step of development first and then later
for postnatal cardiac homeostasis. He et al. showed that Ezh2
is important in regulating heart formation and the perturba-
tion of the epigenetic landscape in early cardiomyogenesis has
disruptive effects at later developmental stages (He and Pu,
2012). In neural stem cells, Ezh2 is crucial for proliferative
activity and maintenance of pluripotency (Sher et al., 2012).
Our experiments point to an essential role for Ezh2 in early
ESC differentiation toward a cardiac lineage by keeping cardiac
transcription factors silenced through epigenetic histone
modifications. Our data reveal how the precocious activation
of cardiogenic transcription factors caused by the removal of
H3K27me3 marks leads to premature activation of cardiac
differentiation via derepression of lineage-specific genes.
On the other side, miR-99a overexpression leads to a
defective Nodal signaling and reduction of Smad2 phosphor-
ylation levels, consistent with a reduced cardiac differenti-
ation. Recent study indicated that miR-99a is important in
modulating the TGF-β-induced epithelial-to-mesenchymal
transition in mammary gland cells by downregulating the
phosphorylation of Smad3 (Turcatel et al., 2012). It is
presently unclear how Smarca5 controls Smad2 signaling,
however we cannot rule out that Smarca5 mediates trans-
criptional silencing of genes belonging to a Nodal pathway,
which eventually results in deregulated Smad2 phosphorylation.
Smarca5 translocates nucleosomes along the DNA in an ATP-
dependentmanner, sampling nucleosomes via transient binding
reactions and become immobilized at active sites during the
cell cycle (Erdel et al., 2010). Therefore, it is tempting to
hypothesize that Smarca5 regulates differentiation by position-
ing nucleosomes on cardiac genes, ‘attracting’ other chromatin
modifier enzymes to activate transcription.Finally, it has been reported that precocious activation of
cardiomyogenesis results in heart defects in vivo (He et al.,
2012; He and Pu, 2012).
Conclusion
In conclusion, our data lead us to hypothesize that imbalance
of these miRNAs could affect cardiac differentiation in vivo.
Although future work is needed to study the role of this
cluster, we showed that overexpression of the miR-99a/let-7c
cluster paralleled the downregulation of their targets in
human DS fetal heart tissues, indicating that the cluster may
play a role in congenital heart defects observed in Down
syndrome. Furthermore, it will be interesting to investigate
whether the miR-99a/let-7c cluster plays any important roles
in other biological context.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2013.11.008.
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